TCM Composition for HPV Treatment via Interferon Mediation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for high-risk Human Papillomavirus (HPV) infections in the female reproductive tract are ineffective and carry significant side effects, with no standardized treatment plan approved for persistent HPV infections, and traditional Chinese medicine approaches lack large-scale clinical validation.
Innovation Solution
A traditional Chinese medicine composition comprising Smilax Glabra Root, Cinnamon Twig, and Commelina Communis, prepared through a process involving decoction, filtration, and concentration, is used to create a pharmaceutical preparation in the form of creams, lotions, or suppositories for treating HPV infections, vaginitis, and cervical ectropion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If physical therapy (laser beam, LEEP procedure, electrocautery) is used to treat HPV infection, then therapeutic effect is improved, but side effects on normal cells increase
Solution Approach 1:
The patent uses interferon as an intermediary substance to treat HPV infection. Instead of directly applying physical therapy that damages normal cells, the interferon mediates the therapeutic effect by inhibiting viral replication through biological mechanisms, thereby achieving treatment while protecting normal cells from harm.
Solution Approach 2:
The patent replaces mechanical/physical therapy methods (laser, electrocautery, wire loop) with a biochemical approach using interferon. This substitution transitions from a mechanical system that physically removes tissue to a biochemical system that selectively inhibits viral replication, reducing damage to normal cells.
2Reliability
If Chinese herbal medicine ingredients are used to exfoliate cervical cells, then HPV infection is treated, but pain and toxicity increase
Solution Approach 1:
The patent changes the parameters of the herbal medicine preparation by using ethanol extraction to obtain specific active ingredients (flavonoids, tannins, alkaloids) rather than using crude herbal extracts. This parameter change in concentration and purity allows for reduced dosage and minimized toxic side effects while maintaining therapeutic efficacy.
3Reliability
If interferon is used to inhibit viral replication, then HPV infection is treated, but normal cells are affected and side effects occur
Solution Approach 1:
The patent creates a composite preparation combining multiple Chinese herbal ingredients (Smilax Glabra Root, Cinnamon Twig, Chinese Knotweed, Commelina Communis) with interferon. This composite formulation enhances the selective antiviral effect while the herbal components modulate the immune response and reduce side effects on normal cells.
Data Source
AI summary
A traditional Chinese medicine composition, a traditional Chinese medicine compound preparation and a preparation method therefor and the use thereof. The traditional Chinese medicine composition and traditional Chinese medicine compound preparation comprise the following raw materials in parts by weight: 30-60 parts of Smilacis glabrae rhizoma, 10-20 parts of Cinnamomi ramulus, 10-20 parts of Polygonum chinense, and 10-20 parts of Commelinae herba. The preparation method comprises water or ethanol extraction, and concentration to make a lotion, suppository, and gel for preparing an anti-human-papillomavirus drug and drugs for treating and/or preventing vaginitis, cervicitis, and cervical ectopic columnar epithelium.